Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

Klaria Pharma Holding AB: Klaria Year-End Report 2023

Klaria Pharma Holding
Download udgivelse

Summary of the interim report

Fourth quarter of 2023

Remaining business operations

- Net sales 0.0 MSEK (2.2 MSEK)

- Other income 0.2 MSEK (0.2 MSEK)

- R&D costs for the quarter amounted to 1.5 MSEK (8.6 MSEK)

- Profit after tax amounted to -7.9 MSEK (-12.9 MSEK)

- Earnings per share for the quarter amounted to -0.07 SEK (-0.22 SEK)

- Cash flow from operating activities amounted to -13.3 MSEK (-10.7 MSEK)

Business operations for sale

- Profit after tax amounted to -1.6 MSEK

The period January-December 2023

Remaining business operations

- Net sales 0.0 MSEK (5.9 MSEK)

- Other income 0.2 MSEK (0.7 MSEK)

- R&D costs for the period amounted to 4.5 MSEK (51.4 MSEK)

- Profit after tax amounted to -18.4 MSEK (-63.8 MSEK)

- Earnings per share for the period amounted to -0.18 SEK (-1.10 SEK)

- Cash flow from operating activities amounted to -15.4 MSEK (-49.8 MSEK)

Business operations for sale

- Profit after tax amounted to -17.4 MSEK

- Earnings per share for the quarter amounted to -0.17 SEK

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.